Hirudin: the next cardiovascular blockbuster?

    loading  Checking for direct PDF access through Ovid


Hirudin could well be the next blockbuster in the cardiovascular pharmaceutical market if discussions at the recent 66th Scientific Sessions of the American Heart Association are anything to go by. This new antithrombotic was the focus of many discussions and presented abstracts at the meeting, which was held in Atlanta, US, in November.

Related Topics

    loading  Loading Related Articles